ÂÜÀòÂÒÂ×

Martin Baraibar is the Founder and CEO of OxiProteomics, SAS, a company established in 2014 that focuses on delivering scientific services related to aging, age-related diseases, and oxidative stress for the dermo-cosmetic and food industries. Currently serving as a Board Member of Cosmetic Valley since September 2021, Martin contributes to promoting the French cosmetics sector internationally. Additionally, as part of OncoDiag's International Business Development team since September 2022, Martin is involved in advancing early cancer diagnostics. Martin's previous roles include Project Manager at Sorbonne University, Research Associate at Indiana University–Purdue University Indianapolis, and Research Assistant at Universidad de la República. Martin holds multiple degrees, including a Ph.D. in Molecular basis of ferritin induced neurodegeneration from Indiana University Indianapolis, and a Master's Degree in Immunotechnology from Universidad de la República.